Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

TScan Therapeutics (TCRX) Preferred Shares Issued (2021)

TScan Therapeutics (TCRX) has disclosed Preferred Shares Issued for 1 consecutive years, with $99.7 million as the latest value for Q1 2021.

  • Quarterly Preferred Shares Issued changed N/A to $99.7 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $99.7 million through Dec 2021, changed N/A year-over-year, with the annual reading at $99.7 million for FY2021, N/A changed from the prior year.
  • Preferred Shares Issued for Q1 2021 was $99.7 million at TScan Therapeutics.
  • The five-year high for Preferred Shares Issued was $99.7 million in Q1 2021, with the low at $99.7 million in Q1 2021.